New pancreatic cancer drug carries a $39,800 monthly list price: What to know
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill…
Better Growth Buy: Axsome vs Revolution Medicines
Axsome Therapeutics (NASDAQ: AXSM) and Revolution Medicines (NASDAQ: RVMD) have offered investors significant growth so far this year.…
NHS ‘simply not ready’ for revolution in dementia care, experts warn | UK | News
Thousands of people with dementia risk missing out on breakthroughs because the NHS is “simply not ready” for…
The Digital Revolution: How Today’s Technology is Shaping Tomorrow
Threads of Hope: The Story of Us Threads of Hope: The Story of Us How Compassion, Curiosity,…